Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| Nippon India Innovation Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| Category | Sectoral / Thematic | Sectoral / Thematic |
| Plan | Direct | Direct |
| Fund house | Nippon India | HDFC |
| NAV | ₹15.4407 | ₹23.6750 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | 3.2 years | 3.1 years |
| Expense ratio | 0.9% | 1.1% |
| Stars | ★★★★★ | ★★★★★ |
| Growth Score | 46.50 | 94.50 |
Returns
| Nippon India Innovation Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| 1 month | +5.54% | +12.97% |
| 3 months | −3.05% | +7.13% |
| 6 months | +8.56% | +17.84% |
| YTD | +4.43% | +33.73% |
| 1 year | +2.54% | +32.20% |
| 3 years (CAGR) | +13.75% | +30.70% |
| 5 years (CAGR) | — | — |
| 10 years (CAGR) | — | — |
| Since launch | +14.13% | +31.83% |
Risk
| Nippon India Innovation Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| Volatility | 17.2% | 15.8% |
| Downside volatility | 11.8% | 8.5% |
| Sharpe | 0.42 | 1.53 |
| Sortino | 0.62 | 2.86 |
| Calmar | 0.64 | 2.06 |
| Return / risk | 0.80 | 1.95 |
| Deepest fall | −21.47% | −14.91% |
| Days to recover | 518 | 126 |
| Below its high | −3.31% | +0.00% |
Against benchmark
| Nippon India Innovation Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| Alpha | +1.93% | +7.54% |
| Beta | 1.00 | 0.97 |
| R² | 88.2% | 85.0% |
| Up capture | 110.0% | 108.9% |
| Down capture | 105.1% | 71.0% |
| Tracking error | 5.9% | 6.1% |
| Information ratio | 0.33 | 1.17 |
| Treynor | 0.06 | 0.24 |
Consistency
| Nippon India Innovation Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| Best 1-year | +51.67% | +67.01% |
| Middle 1-year | +6.12% | +23.25% |
| Worst 1-year | −7.68% | +1.71% |
| 1-year periods with a loss | 7.3% | 0.0% |
| Middle 3-year | +13.78% | +30.22% |
| Positive months | 72.2% | 72.2% |
| Best day | +4.00% | +3.18% |
| Worst day | −3.85% | −3.61% |
| Worst 5% day | −1.59% | −1.51% |
| Positive days | 56.0% | 58.3% |
| NAVs a year | 247 | 247 |
SIP of ₹10,000 a month
| Nippon India Innovation Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| 5-year XIRR | — | — |
| 5-year value | — | — |
| 3-year XIRR | +8.25% | +27.71% |
| 1-year XIRR | +9.91% | +41.37% |
Holdings overlap i
Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.